Trade Summary

3 days ago, Suliman Shehnaaz, serving as Dir at Ultragenyx Pharmaceutical Inc. (RARE), sold 5,740 shares at $25.12 per share, for a total transaction value of $144,189.00. Following this transaction, Suliman Shehnaaz now holds 27,951 shares of RARE.

This sale represents a 17.00% decrease in Suliman Shehnaaz's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 6:41 PM ET, meaning the disclosure happened on the same day as the trade.

Ultragenyx Pharmaceutical Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.